NOTE
🌱 created from: treatment-of-myelofibrosis
COMFORT-I
Verstovsek S. A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis. The New England Journal of Medicine. Published March 1, 2012. Accessed August 24, 2024. https://www.nejm.org/doi/full/10.1056/NEJMoa1110557